Please excuse our appearance as the Care To Live site is being renovated.
Care To Live is forever happy that Dendreon's Provenge was approved by the FDA in April, 2010 for men suffering from prostate cancer. We are still waiting for a Freedom of Information request to be completed by the FDA pertaining to all the e-mails Richard Pazdur sent and received from October 1, 2006 through October 1, 2007. Once we receive the information we requested, we will post it here.
If you have any questions about Dendreon's Provenge, please visit www.Dendreon.com
If you have any questions for Care To Live, please email us: PublicRelations@CareToLive.com